JP Morgan analyst Pablo Singzon maintains Aflac (NYSE:AFL) with a Neutral and lowers the price ta

Company recently launched book, "Beyond Words," leads learning initiative designed to promote kindne

Keefe, Bruyette & Woods analyst Ryan Krueger maintains Aflac (NYSE:AFL) with a Market Perform

Piper Sandler analyst Paul Newsome maintains Aflac (NYSE:AFL) with a Overweight and raises the pr

Aflac remains a quality dividend compounder, but its premium valuation suggests potential near-term

Aflac NYSE: AFL reported second-quarter 2026 net earnings of $1.63 per diluted share and adjusted ea

Aflac Incorporated (AFL) Q2 2026 Earnings Call Transcript

Aflac's Q2 adjusted EPS misses estimates as lower investment income and FX weigh, but U.S. sales, po

Barclays analyst Alex Scott maintains Aflac (NYSE:AFL) with a Underweight and raises the price ta

Although the revenue and EPS for Aflac (AFL) give a sense of how its business performed in the quart

Aflac (AFL) came out with quarterly earnings of $1.75 per share, missing the Zacks Consensus Estimat

Health and life insurer Aflac missed analysts' estimates for second-quarter profit on Thursday, ​hur

COLUMBUS, Ga., Aug. 6, 2026 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its second

Aflac Wellness Matters ® survey reveals wellness paradox: health confidence up, preventive care down

AFL's improved Japan benefit-to-premium ratio may help offset premium and investment income pressure

Evaluate the expected performance of Aflac (AFL) for the quarter ended June 2026, looking beyond the

Aflac (AFL) possesses the right combination of the two key ingredients for a likely earnings beat in

Insurance underwriters and asset managers rarely dominate the headlines, and that is exactly the poi

TD Cowen analyst Andrew Kligerman maintains Aflac (NYSE:AFL) with a Hold and raises the price tar

Aflac has increased its dividend for 43 years, with the latest hike coming in at 5.2%. The company's

JP Morgan analyst Pablo Singzon maintains Aflac (NYSE:AFL) with a Neutral and raises the price ta

As market volatility and shifting economic conditions test investor resolve, high-quality dividend p

Evercore ISI Group analyst Thomas Gallagher maintains Aflac (NYSE:AFL) with a Underperform and ra

[url="]Niagen Bioscience, Inc.[/url] (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide aden

Wall Street analysts change outlook on top names. Complete view of analyst rating changes including

Keefe, Bruyette & Woods analyst Ryan Krueger maintains Aflac (NYSE:AFL) with a Market Perform

Jefferies analyst Suneet Kamath maintains Aflac (NYSE:AFL) with a Hold and raises the price targe

Wells Fargo analyst Wesley Carmichael maintains Aflac (NYSE:AFL) with a Equal-Weight and raises t

Barclays analyst Alex Scott maintains Aflac (NYSE:AFL) with a Underweight and lowers the price ta

On January 1, 2026, we published The 3 Best Dividend Aristocrats to Buy in 2026, naming Aflac (NYSE:

COLUMBUS, Ga., June 30, 2026 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it

Investors need to pay close attention to AFL stock based on the movements in the options market late

Designer Rachel Zoe and Aflac make fashion statement to urge Americans to check for cancer PR Newswi

Aflac (NYSE:AFL) has outperformed the market over the past 5 years by 4.76% on an annualized basis p

Piper Sandler analyst Paul Newsome maintains Aflac (NYSE:AFL) with a Overweight and raises the pr

Morgan Stanley analyst Nigel Dally maintains Aflac (NYSE:AFL) with a Equal-Weight and raises the

Wells Fargo analyst Wesley Carmichael maintains Aflac (NYSE:AFL) with a Equal-Weight and lowers t

Piper Sandler analyst Paul Newsome maintains Aflac (NYSE:AFL) with a Overweight and lowers the pr

Barclays analyst Alex Scott maintains Aflac (NYSE:AFL) with a Underweight and lowers the price ta

Aflac (NYSE:AFL) reported quarterly earnings of $1.75 per share which missed the analyst consensus e

 Up to 51,636,945 Shares of Common Stock​This prospectus relates solely to the resale, from time to

Mizuho analyst Yaron Kinar maintains Aflac (NYSE:AFL) with a Underperform and lowers the price ta

Keefe, Bruyette & Woods analyst Ryan Krueger maintains Aflac (NYSE:AFL) with a Market Perform

Wells Fargo analyst Wesley Carmichael maintains Aflac (NYSE:AFL) with a Equal-Weight and lowers t

UBS analyst Brian Meredith maintains Aflac (NYSE:AFL) with a Neutral and lowers the price target

Keefe, Bruyette & Woods analyst Ryan Krueger reinstates Aflac (NYSE:AFL) with a Market Perfor